Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Gordon · SciRah

Researcher profile · Semantic Scholar

A. Gordon

Share profile

A. Gordon — researcher profile on SciRah

h-index: 29
Works: 78
Citations: 5,232

Most-cited papers

Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan.
A. Gordon, J. Fleagle, D. Guthrie, D. Parkin +2 more
2001Journal of Clinical Oncology1,223 citations
Semantic Scholar
Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.
P. Vasey, G. Jayson, A. Gordon, H. Gabra +6 more
2004Journal of the National Cancer Institute568 citations
Semantic Scholar
Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer.
A. Gordon, M. Tonda, Steven Sun, W. Rackoff
2004Gynecologic Oncology425 citations
Semantic Scholar
Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer.
D. Mutch, M. Orlando, T. Goss, M. Teneriello +7 more
2007Journal of Clinical Oncology373 citations Open access
Semantic Scholar
Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel.
M. Bookman, H. Malmström, G. Bolis, A. Gordon +3 more
1998Journal of Clinical Oncology333 citations
Semantic Scholar
Phase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer.
A. Gordon, C. Granai, P. Rose, J. Hainsworth +4 more
2000Journal of Clinical Oncology332 citations
Semantic Scholar
Efficacy and safety of erlotinib HCl, an epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor, in patients with advanced ovarian carcinoma: results from a phase II multicenter study
A. Gordon, N. Finkler, Robert P. Edwards, A. Garcia +3 more
2004International Journal of Gynecologic Cancer227 citations Open access
Semantic Scholar
Randomized, placebo-controlled study of oregovomab for consolidation of clinical remission in patients with advanced ovarian cancer.
J. Berek, P. Taylor, A. Gordon, M. Cunningham +6 more
2004Journal of Clinical Oncology173 citations Open access
Semantic Scholar
Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer.
C. Lhommé, F. Joly, J. Walker, A. Lissoni +8 more
2008Journal of Clinical Oncology149 citations
Semantic Scholar
Validation of Referral Guidelines for Women With Pelvic Masses
Samuel S. Im, A. Gordon, B. Buttin, C. Leath +5 more
2005Obstetrics and Gynecology110 citations
Semantic Scholar
Role of pegylated liposomal doxorubicin in ovarian cancer.
J. Thigpen, C. Aghajanian, David S. Alberts, S. Campos +5 more
2005Gynecologic Oncology105 citations
Semantic Scholar
CA125- and tumor-specific T-cell responses correlate with prolonged survival in oregovomab-treated recurrent ovarian cancer patients.
A. Gordon, B. Schultes, H. Gallion, R. Edwards +3 more
2004Gynecologic Oncology84 citations
Semantic Scholar
A phase II trial of arzoxifene, a selective estrogen response modulator, in patients with recurrent or advanced endometrial cancer.
D. Mcmeekin, A. Gordon, J. Fowler, A. Melemed +4 more
2003Gynecologic Oncology84 citations
Semantic Scholar
A comparative economic analysis of pegylated liposomal doxorubicin versus topotecan in ovarian cancer in the USA and the UK.
DH Smith, Jared R. Adams, S. Johnston, A. Gordon +2 more
2002Annals of Oncology82 citations Open access
Semantic Scholar
Pegfilgrastim on the Same Day Versus Next Day of Chemotherapy in Patients With Breast Cancer, Non-Small-Cell Lung Cancer, Ovarian Cancer, and Non-Hodgkin's Lymphoma: Results of Four Multicenter, Double-Blind, Randomized Phase II Studies.
H. Burris, C. Belani, P. Kaufman, A. Gordon +5 more
2010Journal of Oncology Practice79 citations Open access
Semantic Scholar
The Immune Adjuvant Properties of Front-line Carboplatin-Paclitaxel: A Randomized Phase 2 Study of Alternative Schedules of Intravenous Oregovomab Chemoimmunotherapy in Advanced Ovarian Cancer
P. Braly, C. Nicodemus, C. Chu, Y. Collins +7 more
2009Journal of immunotherapy61 citations
Semantic Scholar
SQUAMOUS CARCINOMA OF THE CERVIX COMPLICATING PREGNANCY: RECURRENCE IN EPISIOTOMY AFTER VAGINAL DELIVERY
A. Gordon, R. Jensen, H. Jones
1989Obstetrics and Gynecology54 citations
Semantic Scholar
Overexpression of Tissue VEGF-A May Portend an Increased Likelihood of Progression in a Phase II Trial of Bevacizumab and Erlotinib in Resistant Ovarian Cancer
S. Chambers, M. Clouser, A. Baker, D. Roe +11 more
2010Clinical Cancer Research51 citations Open access
Semantic Scholar
A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma
S. Chan, A. Gordon, R. Coleman, J. Hall +4 more
2003Cancer Immunology and Immunotherapy51 citations Open access
Semantic Scholar
Liposomal anthracycline treatment for ovarian cancer.
M. Markman, A. Gordon, W. Mcguire, F. Muggia
2004Seminars in Oncology48 citations
Semantic Scholar
Sarcoma botryoides of the cervix: excision followed by adjuvant chemotherapy for preservation of reproductive function.
A. Gordon, T. Montag
1990Gynecologic Oncology40 citations
Semantic Scholar
Detection of human papillomavirus DNA in advanced epithelial ovarian carcinoma.
Raymond H. Kaufman, Jacob Bornstein, A. Gordon, E. Adam +2 more
1987Gynecologic Oncology38 citations
Semantic Scholar
High-Risk Metastatic Gestational Trophoblastic Disease
A. Gordon, D. Gershenson, L. Copeland, P. B. Saul +2 more
1985Obstetrics and Gynecology38 citations
Semantic Scholar
Phase I dose escalation of paclitaxel in patients with advanced ovarian cancer receiving cisplatin: rapid development of neurotoxicity is dose-limiting.
A. Gordon, C. Stringer, C. Matthews, D. Willis +1 more
1997Journal of Clinical Oncology36 citations
Semantic Scholar
Early changes in CA125 after treatment with pegylated liposomal doxorubicin or topotecan do not always reflect best response in recurrent ovarian cancer patients.
R. Coleman, A. Gordon, J. Barter, Steven Sun +2 more
2007The Oncologist33 citations Open access
Semantic Scholar
Primary malignant melanoma of the vagina; Report of four cases and review of the literature
Z. Levitan, A. Gordon, A. Kaplan, Raymond H. Kaufman
1989Gynecologic Oncology32 citations
Semantic Scholar
A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer.
M. Seiden, A. Gordon, D. Bodurka, U. Matulonis +6 more
2006Gynecologic Oncology31 citations
Semantic Scholar
Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer.
A. Gordon, M. Teneriello, M. Janicek, J. Hines +12 more
2011Gynecologic Oncology30 citations
Semantic Scholar
Human papillomavirus associated with adenocarcinoma and adenosquamous carcinoma of the cervix: analysis by in situ hybridization
A. Gordon, Jacob Bornstein, Raymond H. Kaufman, Rolando Estrada +2 more
1989Gynecologic Oncology30 citations
Semantic Scholar
Suicide by poisoning.
G. Hutchinson, H. Daisley, V. Simmons, A. Gordon
1991West Indian medical journal27 citations
Semantic Scholar
Early discharge after vaginal hysterectomy.
A. Gordon
1988Obstetrics and Gynecology26 citations
Semantic Scholar
Small-cell carcinoma of the ovary: an aggressive epithelial cancer occurring in young patients.
Kathleen M. Pruett, A. Gordon, Rolando Estrada, G. Lynch
1988Gynecologic Oncology25 citations
Semantic Scholar
Successful treatment of leptomeningeal relapse of epithelial ovarian cancer.
A. Gordon, J. Kavanagh, J. Wharton, F. Rutledge +2 more
1984Gynecologic Oncology24 citations
Semantic Scholar
Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early-stage high-risk endometrial cancer: a preliminary analysis.
C. Stringer, D. Gershenson, T. Burke, C. Edwards +2 more
199021 citations
Semantic Scholar
Benign cystic teratomas in postmenopausal women.
A. Gordon, Neil B. Rosenshein, T. Parmley, B. Bhagavan
1980American Journal of Obstetrics and Gynecology21 citations
Semantic Scholar
A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer.
I. Vergote, R. Schilder, C. Pippitt, Shirley S. Wong +12 more
2014Gynecologic Oncology20 citations Open access
Semantic Scholar
Phase I study of alternating doublets of topotecan/carboplatin and paclitaxel/carboplatin in patients with newly diagnosed, advanced ovarian cancer.
A. Gordon, K. Hancock, C. Matthews, M. Messing +3 more
2002Gynecologic Oncology12 citations
Semantic Scholar
Survival after malignant pericardial effusion and cardiac tamponade in advanced ovarian cancer.
Zohar Levitan, Alan L. Kaplan, A. Gordon
1990Southern medical journal (Birmingham, Ala. Print)12 citations
Semantic Scholar
Folate Receptor Alpha Is Preferentially Expressed in the Carcinoma Component of Endometrial Carcinosarcomas: A Potential Target for Adjuvant Therapy
Krisztina Z. Hanley, I. Horowitz, A. Gordon, J. Meisel +1 more
2020International Journal of Gynecological Pathology10 citations
Semantic Scholar
Sigmoidovaginal fistula secondary to diverticular disease. A report of three cases.
Keith O. Reeves, Ronald L. Young, A. Gordon, S. Thomas +2 more
1988Journal of reproductive medicine10 citations
Semantic Scholar
Phase II study of sequential doublets: topotecan and carboplatin, followed by paclitaxel and carboplatin, in patients with newly diagnosed advanced ovarian cancer.
A. Gordon, L. Asmar, M. Messing, D. Street +4 more
2004Gynecologic Oncology9 citations
Semantic Scholar
A phase I/II dose escalation study of carboplatin in the treatment of newly diagnosed patients with advanced ovarian cancer receiving paclitaxel.
A. Gordon, K. Hancock, C. Matthews, C. Stringer +2 more
1999American Journal of Clinical Oncology8 citations
Semantic Scholar
30-day postoperative adverse events in minimally invasive versus open abdominal radical hysterectomy for early-stage cervical cancer.
A. Kohut, T. Kuhn, L. Conrad, K. J. Chua +6 more
2022Journal of minimally invasive gynecology7 citations
Semantic Scholar
Conflicting phase II efficacy data for Doxil.
Gregory Frykman, G. Williams, R. Pazdur, A. Gordon
2001Journal of Clinical Oncology7 citations
Semantic Scholar
Phase I study of topotecan (T) with carboplatin (C) alternating with paclitaxel (P) via 3 hour infusion with carboplatin (C) in treatment of newly diagnosed ovarian cancer (OC)
A. Gordon, M. Doherty, K. Hancock, M. Messing +4 more
19997 citations
Semantic Scholar
Phase Ib study of AMG 386 combined with either pegylated liposomal doxorubicin (PLD) or topotecan (T) in patients with advanced ovarian cancer.
R. Wenham, J. Leach, S. Scudder, B. Amin +6 more
20106 citations
Semantic Scholar
Phase III trial of induction gemcitabine (G) or paclitaxel (T) plus carboplatin (C) followed by elective T consolidation in advanced ovarian cancer (OC): Interim analysis of induction chemotherapy
A. Gordon, M. Teneriello, N. Spirtos, M. Janicek +6 more
20086 citations
Semantic Scholar
Prospective evaluation of front-line chemo-immunotherapy (C-IT) with oregovomab (2 alternative dosing schedules) carboplatin-paclitaxel (C-P) in advanced ovarian cancer (OC)
P. Braly, C. Chu, Y. Collins, R. Edwards +5 more
20076 citations
Semantic Scholar
Chemotherapeutic management of advanced ovarian cancer.
A. Gordon, J. Butler
2003Seminars in Oncology Nursing5 citations
Semantic Scholar
Response of lower genital tract flora to external pelvic irradiation.
A. Gordon, Mark G. Martens, Yvetta LaPread, S. Faro
1989Gynecologic Oncology5 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Teneriello×5
Invite
M. Teneriello — researcher profile on SciRah
C. Stringer×5
Invite
C. Stringer — researcher profile on SciRah
C. Nicodemus×4
Invite
C. Nicodemus — researcher profile on SciRah
W. Mcguire×4
Invite
W. Mcguire — researcher profile on SciRah

×4

Invite

C. Matthews — researcher profile on SciRah

Invite

M. Orlando — researcher profile on SciRah

Yan-Ping Wang×3

Invite

Yan-Ping Wang — researcher profile on SciRah

Invite

N. Finkler — researcher profile on SciRah

T. Whiteside×3

Invite

T. Whiteside — researcher profile on SciRah

Invite

R. Edwards — researcher profile on SciRah

Invite

M. Janicek — researcher profile on SciRah

Raymond H. Kaufman×3

Invite

Raymond H. Kaufman — researcher profile on SciRah